These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7054998)

  • 1. A new nonvascular interpretation of syncopal migraine.
    Sicuteri F; Boccuni M; Fanciullacci M; D'Egidio P; Bonciani M
    Adv Neurol; 1982; 33():199-208. PubMed ID: 7054998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man.
    Svet-Moldavsky I; Svet-Moldavsky G; Zinzar S; Holland J; Vergara C; Arlin Z; Koziner B; Clarkson B
    Biomedicine; 1981 Oct; 35(5):142-4. PubMed ID: 6797487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent syncope, hypotension, asthma, and migraine with aura: role of metoclopramide.
    Gupta VK
    Headache; 2005; 45(10):1413-6. PubMed ID: 16324177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats.
    Lahlou S
    Pharmacol Toxicol; 2001 May; 88(5):238-43. PubMed ID: 11393583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine involvement in the migraine attack.
    Fanciullacci M; Alessandri M; Del Rosso A
    Funct Neurol; 2000; 15 Suppl 3():171-81. PubMed ID: 11200788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine hypersensitivity in migraine: role in apomorphine syncope.
    Del Zompo M; Lai M; Loi V; Pisano MR
    Headache; 1995 Apr; 35(4):222-4. PubMed ID: 7775179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological exploration of dopamine hypersensitivity in migraine patients.
    Bès A; Dupui P; Güell A; Bessoles G; Géraud G
    Int J Clin Pharmacol Res; 1986; 6(3):189-92. PubMed ID: 3744624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine blockade with domperidone: bridge between prophylactic and abortive treatment of migraine? A dose-finding study.
    Waelkens J
    Cephalalgia; 1984 Jun; 4(2):85-90. PubMed ID: 6375874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metoclopramide blocks bromocriptine induced antihypertensive effect in hypertensive patients.
    Luchsinger A; Grilli M; Forte P; Morales E; Velasco M
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):509-12. PubMed ID: 8520809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peripheral presynaptic dopamine receptors control the release of norepinephrine and arterial pressure in humans].
    Mercuro G; Rossetti Z; Rivano AC; Tocco L; Ruscazio M; Stefanini E; Gessa GL; Cherchi A
    Cardiologia; 1987 Jul; 32(7):643-50. PubMed ID: 3690588
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects on arterial pressure of administration of a single dose (5 mg/per os) of bromocryptine].
    Steardo L; Sorge F; Florio C; Marano E; Bonuso S; de Martino G
    Acta Neurol Quad (Napoli); 1978; 37():98-104. PubMed ID: 757112
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dopaminergic disequilibria in hemicrania].
    Boccuni M; Cangi F; Del Bene E; Fusco BM; Sicuteri F
    Acta Neurol (Napoli); 1985 Apr; 7(2):135-53. PubMed ID: 2990173
    [No Abstract]   [Full Text] [Related]  

  • 13. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group.
    Headache; 1998 Mar; 38(3):173-83. PubMed ID: 9563207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of dopamine in a model of trigeminovascular nociception.
    Akerman S; Goadsby PJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):162-9. PubMed ID: 15778266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine.
    Sprah L; Zivin M; Sket D
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1093-100. PubMed ID: 10027846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epilepsy and migraine: The dopamine hypotheses.
    Chen SC
    Med Hypotheses; 2006; 66(3):466-72. PubMed ID: 16298497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone.
    Cavero I; Lefèvre-Borg F; Gomeni R
    J Pharmacol Exp Ther; 1981 Aug; 218(2):515-24. PubMed ID: 7252851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dopaminergic antagonists on dopamine-induced cardiovascular and insulin secretion actions in hypertensive patients.
    Forte P; Martin G; Luchsinger A; Hernandez O; Romero E; Velasco M
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):404-6. PubMed ID: 8225687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a fixed combination of domperidone and paracetamol (Domperamol) with sumatriptan 50 mg in moderate to severe migraine: a randomised UK primary care study.
    Dowson A; Ball K; Haworth D
    Curr Med Res Opin; 2000; 16(3):190-7. PubMed ID: 11191009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of migraine by modulating dopamine hypersensitivity: its effect on mood and pain.
    Lai M; Loi V; Pisano MR; Del Zompo M
    Int J Clin Pharmacol Res; 1997; 17(2-3):101-3. PubMed ID: 9403364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.